The COVID-19 (coronavirus) pandemic has had a huge impact on healthcare resources andstaff in the UK. Understanding the key risk factors associated with infection amongsthealthcare workers is essential for future pandemic response plans.Currently there are scarce data relating to the infection rates and associated factorsamongst healthcare workers in the United Kingdom (UK). Studies of infection rates inhealthcare workers have largely relied on the real-time reverse transcriptase-polymerasechain reaction (RT-PCR) test to date and it appears that Healthcare workers are twice aslikely to succumb to Coronavirus infection, when compared to the general population andthose from Black and minority ethnic (BAME) backgrounds appear to be particularly atrisk.Currently there is no evidence that the presence of SARS-CoV-2 (severe acute respiratorysyndrome coronavirus 2) antibodies provides seasonal or long term immunity to futureinfection.Therefore, this study aims to understand the current level of SARS-CoV-2 antibodypositivity and try to determine the likely risk to healthcare workers in the UK toCOVID-19 infection. This study hopes to find out whether certain individualcharacteristics will have an impact on likelihood of infection susceptibility andantibody response and determine the impact of the presence of antibodies on thelikelihood of future clinical infection over a 12 month period.The study involves an initial online survey and linkage to the recent antibody test, thena further online survey in 6 and 12 months' time. The data obtained will be linked todata that the Human Resources Department (HR) holds.Participants also have the option to partake in another antibody test at 6 and 12 months'time and linked to the data collected.
Participants will have access to the study via the link given in an SMS (Short Message
Service - text message) which will direct then to the first online survey.
They will then be contacted again in 6 and 12 months' time to complete the online survey
again.
The survey answers will be linked to the results of the antibody tests by their mobile
and Employment Number and also to data held about them by the HR Department.
The survey will take approximately 15 minutes to complete and will include questions on
the following: profession; work-line type; demographics and behavioural factors;
ethnicity; and symptoms (if COVID 19 was manifested).
Participants can also attend for another blood test (SARS-CoV-2 (severe acute respiratory
syndrome coronavirus 2) antibody test) to detect any presence of antibodies at 6 and 12
months (optional) which will again be linked to the survey and HR data.
Other: Survey
Survey at baseline, 6 and 12 months
Diagnostic Test: SARS-CoV-2 antibody test
SARS-CoV-2 antibody test results and testing again at 6 and 12 months
Inclusion Criteria:
- All Staff employed by Royal Wolverhampton Trust, having undergone the
SARS-CoV-2antibody test at the Trust's testing facility
Exclusion Criteria:
- Royal Wolverhampton NHS Trust staff who have not participated in antibody testing •
Staff who have opted out to receiving the text message invite and be part of the
study
The Royal Wolverhampton NHS Trust
Wolverhampton, United Kingdom
Supratik Basu, Principal Investigator
The Royal Wolverhampton NHS Trust